BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 10731399)

  • 1. Systematic review of the management of atrial fibrillation in patients with heart failure.
    Khand AU; Rankin AC; Kaye GC; Cleland JG
    Eur Heart J; 2000 Apr; 21(8):614-32. PubMed ID: 10731399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of symptomatic atrial fibrillation.
    Haghi D; Schumacher B
    Am J Cardiovasc Drugs; 2001; 1(2):127-39. PubMed ID: 14728042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the older person with atrial fibrillation.
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2002 Jun; 57(6):M352-63. PubMed ID: 12023264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
    Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
    Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation.
    Samuels LE; Holmes EC; Samuels FL
    Ann Thorac Surg; 2005 Jan; 79(1):113-6. PubMed ID: 15620926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B; Curtis AB
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early outcome of initiating amiodarone for atrial fibrillation in advanced heart failure.
    Weinfeld MS; Drazner MH; Stevenson WG; Stevenson LW
    J Heart Lung Transplant; 2000 Jul; 19(7):638-43. PubMed ID: 10930812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the older person with atrial fibrillation.
    Aronow WS
    J Am Geriatr Soc; 1999 Jun; 47(6):740-8. PubMed ID: 10366178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis.
    Shin DG; Cho I; Hartaigh Bó; Mun HS; Lee HY; Hwang ES; Park JK; Uhm JS; Pak HN; Lee MH; Joung B
    Yonsei Med J; 2015 Nov; 56(6):1552-8. PubMed ID: 26446636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation--control of heart rate--cardioversion. Therpeutic algorithm in ventricular tachycardia].
    Steinbigler P; Haberl R
    MMW Fortschr Med; 2003 Apr; 145(17):34-6. PubMed ID: 12808801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
    Siu CW; Lau CP; Lee WL; Lam KF; Tse HF
    Crit Care Med; 2009 Jul; 37(7):2174-9; quiz 2180. PubMed ID: 19487941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.